Seattle-based Proprio designed the Paradigm surgical navigation platform to replace traditional surgical navigation technologies. It uses an advanced approach to avoid pitfalls that pull attention away from the patient and disrupt workflows.
This approach utilizes the fusing of light field imaging technology and AI. It gives surgical teams 3D visualization of both anatomical structures and the surgical environment. The FDA cleared Paradigm in April.
Dr. Richard J. Bransford of the University of Washington Harborview Medical Center performed the procedure.
“The use of Paradigm in our surgical environment is a game-changer representing the future of spinal surgery,” Bransford said. “The real-time 3D imagery allowed us to visualize the patient’s anatomy in ways not previously available to us. That will ultimately enable us to drive better outcomes for patients.”
Paradigm uses advanced sensors and cameras to capture high-definition, multimodal images during surgery. It integrates them with preoperative scans to provide real-time anatomical mapping. Using Paradigm, surgeons can gain access to valuable intraoperative insights and powerful visualization tools.
Real-time data from Paradigm helps surgeons move away from costly scans that can cause radiation exposure and disrupt clinical workflows, Proprio says. The system also collects large amounts of pre-operative and intra-operative data to inform decision-making.
“The successful first-in-human use of Paradigm marks a pivotal milestone in our journey to enhance the future of surgery,” said Gabriel Jones, CEO and co-founder of Proprio. “We are honored by this validation of the potential of our platform to reshape surgical practices and drive meaningful reductions in costs, increasing access to essential healthcare.”
